Indivior PLC (INDV) 10-Year Financial Performance & Capital Metrics

INDV • • Industrial / General

HealthcareSpecialty & Generic PharmaSpecialty PharmaceuticalsAddiction Treatment

AboutIndivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder. The company also offers OPVEE nasal spray for opioid overdose reversal; and PERSERIS extended-release injectable suspension for the treatment of schizophrenia in adults. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that completed phase 1 clinical trial for the treatment of opioid use disorder (OUD); INDV-1000, a selective GABAb positive allosteric modulator, which is in pre-clinical development phase for the treatment of alcohol use disorder in collaboration with ADDEX therapeutics; INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc.; and CT-102, a digital therapeutic for the treatment of OUD in collaboration with Click Therapeutics. Further, the company is developing INDV-5004, a drinabant injection to treat acute cannabinoid overdose. It has a strategic partnership with Aelis Farma to develop AEF0117, a synthetic CB1 specific signaling inhibitor that is in phase 2B clinical trial for the treatment of cannabis use disorder. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.Show more

Revenue $1.19B +8.7%
EBITDA $61M +143.3%
Net Income $2M +101.6%
EPS (Diluted) 0.02 +6.4%
Gross Margin 80.56% -4.2%
EBITDA Margin 5.13% +139.8%
Operating Margin 2.69% +118.9%
Net Margin 0.17% +101.4%
ROE -
ROIC -
Debt/Equity -
Interest Coverage 0.78 +117.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 92 (top 8%)
✓High quality earnings: Operating CF exceeds net income
✓Share count reduced 6.2% through buybacks

✗Weaknesses

✗Profits declining 56.9% over 5 years

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y8.64%

3Y14.52%

TTM-0.17%

Profit (Net Income) CAGR

10Y-

5Y-56.87%

3Y-78.63%

TTM654.55%

EPS CAGR

10Y-

5Y-56.1%

3Y-77.46%

TTM828.57%

ROCE

10Y Avg38.5%

5Y Avg-4.44%

3Y Avg-9%

Latest7.49%

Peer Comparison

Addiction Treatment

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
INDVIndivior PLC	4.11B	32.89	2192.33	8.69%	14.06%		0.17%

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	968.89M	1.15B	959.92M	785M	647M	791M	901M	1.09B	1.19B
Revenue Growth %	-	0.18%	-0.16%	-0.18%	-0.18%	0.22%	0.14%	0.21%	0.09%
Cost of Goods Sold+	110.81M	122.9M	134.68M	140M	97M	127M	151M	174M	231M
COGS % of Revenue	0.11%	0.11%	0.14%	0.18%	0.15%	0.16%	0.17%	0.16%	0.19%
Gross Profit+	858.08M	1.03B	825.25M	645M	550M	664M	750M	919M	957M
Gross Margin %	0.89%	0.89%	0.86%	0.82%	0.85%	0.84%	0.83%	0.84%	0.81%
Gross Profit Growth %	-	0.19%	-0.2%	-0.22%	-0.15%	0.21%	0.13%	0.23%	0.04%
Operating Expenses+	520.16M	601.89M	508.14M	467M	706M	451M	831M	1.07B	925M
OpEx % of Revenue	0.54%	0.52%	0.53%	0.59%	1.09%	0.57%	0.92%	0.98%	0.78%
Selling, General & Admin	411.18M	508.4M	444.14M	395M	649M	431M	469M	569M	618M
SG&A % of Revenue	0.42%	0.44%	0.46%	0.5%	1%	0.54%	0.52%	0.52%	0.52%
Research & Development	108.98M	93.49M	63.99M	53M	40M	52M	74M	116M	107M
R&D % of Revenue	0.11%	0.08%	0.07%	0.07%	0.06%	0.07%	0.08%	0.11%	0.09%
Other Operating Expenses	0	0	0	19M	17M	-32M	288M	390M	200M
Operating Income+	337.92M	423.32M	317.11M	178M	-156M	213M	-81M	-156M	32M
Operating Margin %	0.35%	0.37%	0.33%	0.23%	-0.24%	0.27%	-0.09%	-0.14%	0.03%
Operating Income Growth %	-	0.25%	-0.25%	-0.44%	-1.88%	2.37%	-1.38%	-0.93%	1.21%
EBITDA+	350.74M	436.97M	332.39M	206M	-130M	235M	-65M	-141M	61M
EBITDA Margin %	0.36%	0.38%	0.35%	0.26%	-0.2%	0.3%	-0.07%	-0.13%	0.05%
EBITDA Growth %	-	0.25%	-0.24%	-0.38%	-1.63%	2.81%	-1.28%	-1.17%	1.43%
D&A (Non-Cash Add-back)	12.82M	13.66M	15.28M	28M	26M	22M	16M	15M	29M
EBIT	136.45M	193M	295.14M	202M	-149M	216M	-62M	-114M	55M
Net Interest Income+	-51M	-42M	-14M	2M	-17M	-22M	-10M	8M	-18M
Interest Income	0	7M	17M	24M	7M	4M	19M	43M	23M
Interest Expense	51M	49M	31M	22M	24M	26M	29M	35M	41M
Other Income/Expense	-51M	-56M	-14M	2M	-17M	-23M	-8M	7M	-18M
Pretax Income+	89.75M	143.91M	265.53M	180M	-173M	190M	-89M	-149M	14M
Pretax Margin %	0.09%	0.13%	0.28%	0.23%	-0.27%	0.24%	-0.1%	-0.14%	0.01%
Income Tax+	57.69M	82.98M	2.87M	46M	-25M	-15M	-44M	-20M	11M
Effective Tax Rate %	0.36%	0.42%	0.99%	0.74%	0.86%	1.08%	0.49%	0.87%	0.14%
Net Income+	32.05M	60.92M	262.67M	134M	-148M	205M	-44M	-129M	2M
Net Margin %	0.03%	0.05%	0.27%	0.17%	-0.23%	0.26%	-0.05%	-0.12%	0%
Net Income Growth %	-	0.9%	3.31%	-0.49%	-2.1%	2.39%	-1.21%	-1.93%	1.02%
Net Income (Continuing)	32.05M	60.92M	262.67M	134M	-148M	205M	-45M	-129M	3M
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	0.22	0.41	1.75	0.92	-1.08	1.31	-0.37	0.01	0.02
EPS Growth %	-	0.86%	3.27%	-0.47%	-2.17%	2.21%	-1.28%	1.04%	0.06%
EPS (Basic)	0.22	0.42	1.81	0.95	-1.08	1.38	-0.37	0.01	0.02
Diluted Shares Outstanding	148.64M	149.7M	150.23M	151.07M	146.57M	154.23M	139.01M	141.8M	133M
Basic Shares Outstanding	143.97M	144.23M	145.43M	146.05M	146.57M	145.66M	139.01M	137.31M	132M
Dividend Payout Ratio	1.97%	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	990M	1.22B	1.33B	1.36B	1.19B	1.44B	1.27B	1.27B	839M
Cash & Short-Term Investments	692M	863M	924M	1.06B	858M	1.1B	897.83M	410M	320M
Cash Only	692M	863M	924M	1.06B	858M	1.1B	778.18M	316M	319M
Short-Term Investments	0	0	0	0	0	0	119.64M	94M	1M
Accounts Receivable	205M	257M	278M	204M	219M	202M	220M	254M	254M
Days Sales Outstanding	77.23	81.7	105.71	94.85	123.55	93.21	89.12	84.82	78.04
Inventory	41M	52M	78M	73M	93M	95M	114.62M	135M	178M
Days Inventory Outstanding	135.05	154.44	211.4	190.32	349.95	273.03	277.05	283.19	281.26
Other Current Assets	40M	38M	49M	0	0	27M	18M	444M	87M
Total Non-Current Assets+	219M	219M	218M	292M	344M	388M	512.76M	499M	481M
Property, Plant & Equipment	27M	54M	57M	107M	103M	95M	85.46M	124M	139M
Fixed Asset Turnover	35.88x	21.26x	16.84x	7.34x	6.28x	8.33x	10.54x	8.81x	8.55x
Goodwill	0	0	0	0	0	0	0	0	2M
Intangible Assets	0	0	0	72M	62M	82M	70M	13M	5M
Long-Term Investments	0	15M	33M	0	0	0	98.53M	41M	26M
Other Non-Current Assets	83M	92M	84M	73M	104M	106M	38.58M	28M	29M
Total Assets+	1.21B	1.44B	1.55B	1.65B	1.53B	1.83B	1.78B	1.76B	1.32B
Asset Turnover	0.80x	0.80x	0.62x	0.48x	0.42x	0.43x	0.51x	0.62x	0.90x
Asset Growth %	-	0.19%	0.07%	0.07%	-0.07%	0.2%	-0.03%	-0.01%	-0.25%
Total Current Liabilities+	1.03B	854M	818M	742M	599M	804M	1.02B	1.29B	939M
Accounts Payable	33M	40M	47M	499M	416M	26M	33M	39M	63M
Days Payables Outstanding	108.7	118.8	127.38	1.3K	1.57K	74.72	79.77	81.81	99.55
Short-Term Debt	101M	5M	4M	9M	12M	3M	3M	12M	18M
Deferred Revenue (Current)	1000K	1000K	1000K	0	0	0	1000K	0	0
Other Current Liabilities	673M	617M	603M	195M	156M	635M	391M	1.16B	802M
Current Ratio	0.96x	1.43x	1.62x	1.83x	1.98x	1.80x	1.24x	0.98x	0.89x
Quick Ratio	0.92x	1.37x	1.53x	1.73x	1.83x	1.68x	1.12x	0.88x	0.70x
Cash Conversion Cycle	103.58	117.34	189.72	-1.02K	-1.09K	291.52	286.41	286.2	259.75
Total Non-Current Liabilities+	474M	793M	663M	701M	850M	825M	702.78M	666M	728M
Long-Term Debt	434M	477M	237M	233M	230M	239M	237M	237M	315M
Capital Lease Obligations	0	0	0	51M	43M	36M	29M	34M	32M
Deferred Tax Liabilities	0	0	0	0	0	0	0	5M	0
Other Non-Current Liabilities	40M	316M	426M	417M	577M	550M	436.78M	390M	381M
Total Liabilities	1.5B	1.65B	1.48B	1.44B	1.45B	1.63B	1.73B	1.96B	1.67B
Total Debt+	535M	482M	241M	293M	285M	286M	277M	283M	375M
Net Debt	-157M	-381M	-683M	-767M	-573M	-816M	-501.18M	-33M	56M
Debt / Equity	-	-	3.65x	1.40x	3.48x	1.41x	5.40x	-	-
Debt / EBITDA	1.53x	1.10x	0.73x	1.42x	-	1.22x	-	-	6.15x
Net Debt / EBITDA	-0.45x	-0.87x	-2.05x	-3.72x	-	-3.47x	-	-	0.92x
Interest Coverage	6.63x	8.64x	10.23x	8.09x	-6.50x	8.19x	-2.79x	-4.46x	0.78x
Total Equity+	-295M	-203M	66M	209M	82M	203M	51.28M	-191M	-348M
Equity Growth %	-	0.31%	1.33%	2.17%	-0.61%	1.48%	-0.75%	-4.72%	-0.82%
Book Value per Share	-1.98	-1.36	0.44	1.38	0.56	1.32	0.37	-1.35	-2.62
Total Shareholders' Equity	-295M	-203M	66M	209M	82M	203M	51.28M	-191M	-348M
Common Stock	72M	72M	73M	73M	73M	70M	68.37M	68M	62M
Retained Earnings	950M	1.03B	1.31B	1.45B	1.31B	1.44B	1.31B	-295M	-454M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	-1.32B	-1.31B	-1.33B	-1.32B	-1.31B	0	-1.34B	-1.35B	-46M
Minority Interest	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	372.72M	309.87M	289.41M	151M	-193M	353M	-4M	-300M	36M
Operating CF Margin %	0.38%	0.27%	0.3%	0.19%	-0.3%	0.45%	-0%	-0.27%	0.03%
Operating CF Growth %	-	-0.17%	-0.07%	-0.48%	-2.28%	2.83%	-1.01%	-74%	1.12%
Net Income	32.05M	60.92M	262.67M	178M	-156M	213M	-44M	-129M	2M
Depreciation & Amortization	12.82M	13.66M	15.28M	28M	26M	22M	16M	15M	29M
Stock-Based Compensation	0	0	0	3M	8M	11M	16M	21M	24M
Deferred Taxes	0	0	0	0	0	0	0	0	6M
Other Non-Cash Items	-65.02M	177.52M	20.06M	21M	-52M	-66M	-110M	87M	16M
Working Capital Changes	309.53M	148.11M	27.7M	-79M	-19M	173M	118M	-294M	-41M
Change in Receivables	-24.73M	-61.97M	-31.52M	79M	15M	-25M	-21M	-33M	-1M
Change in Inventory	3.66M	-6.3M	-29.61M	7M	-16M	-3M	-30M	-15M	-45M
Change in Payables	130.04M	5.25M	55.4M	0	0	0	0	0	0
Cash from Investing+	-32.05M	-45.17M	-3.82M	-2M	-4M	-14M	-222M	-95M	69M
Capital Expenditures	-32.05M	-45.17M	-39.16M	-7M	-4M	-4M	-5M	-8M	-29M
CapEx % of Revenue	0.03%	0.04%	0.04%	0.01%	0.01%	0.01%	0.01%	0.01%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-
Other Investing	0	0	35.34M	5M	0	-10M	1M	-42M	-2M
Cash from Financing+	-134.62M	-88.23M	-226.37M	-13M	-10M	-94M	-101M	-64M	-102M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-
Dividends Paid	-63.19M	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-
Other Financing	12.38M	0	-10.76M	-9M	-7M	-8M	-10M	-22M	-24M
Net Change in Cash	-	-	-	-	-	-	-	-	-
Free Cash Flow+	340.67M	264.7M	250.25M	144M	-197M	319M	-9M	-353M	7M
FCF Margin %	0.35%	0.23%	0.26%	0.18%	-0.3%	0.4%	-0.01%	-0.32%	0.01%
FCF Growth %	-	-0.22%	-0.05%	-0.42%	-2.37%	2.62%	-1.03%	-38.22%	1.02%
FCF per Share	2.29	1.77	1.67	0.95	-1.34	2.07	-0.06	-2.49	0.05
FCF Conversion (FCF/Net Income)	11.63x	5.09x	1.10x	1.13x	1.30x	1.72x	0.09x	2.33x	18.00x
Interest Paid	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	397.98%	97.45%	-101.72%	143.86%	-34.61%	-	-
Gross Margin	88.56%	89.3%	85.97%	82.17%	85.01%	83.94%	83.24%	84.08%	80.56%
Net Margin	3.31%	5.31%	27.36%	17.07%	-22.87%	25.92%	-4.88%	-11.8%	0.17%
Debt / Equity	-	-	3.65x	1.40x	3.48x	1.41x	5.40x	-	-
Interest Coverage	6.63x	8.64x	10.23x	8.09x	-6.50x	8.19x	-2.79x	-4.46x	0.78x
FCF Conversion	11.63x	5.09x	1.10x	1.13x	1.30x	1.72x	0.09x	2.33x	18.00x
Revenue Growth	-	18.5%	-16.39%	-18.22%	-17.58%	22.26%	13.91%	21.31%	8.69%

Revenue by Geography

	2023	2024
UNITED STATES	912M	3M
UNITED STATES Growth	-	-99.67%

Frequently Asked Questions

Growth & Financials

Indivior PLC (INDV) reported $1.18B in revenue for fiscal year 2024. This represents a 22% increase from $968.9M in 2016.

Indivior PLC (INDV) grew revenue by 8.7% over the past year. This is steady growth.

Yes, Indivior PLC (INDV) is profitable, generating $166.0M in net income for fiscal year 2024 (0.2% net margin).

Dividend & Returns

Indivior PLC (INDV) generated $135.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Indivior PLC (INDV) 10-Year Financial Performance & Capital Metrics

INDV • • Industrial / General

HealthcareSpecialty & Generic PharmaSpecialty PharmaceuticalsAddiction Treatment

Revenue $1.19B +8.7%
EBITDA $61M +143.3%
Net Income $2M +101.6%
EPS (Diluted) 0.02 +6.4%
Gross Margin 80.56% -4.2%
EBITDA Margin 5.13% +139.8%
Operating Margin 2.69% +118.9%
Net Margin 0.17% +101.4%
ROE -
ROIC -
Debt/Equity -
Interest Coverage 0.78 +117.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 92 (top 8%)
✓High quality earnings: Operating CF exceeds net income
✓Share count reduced 6.2% through buybacks

✗Weaknesses

✗Profits declining 56.9% over 5 years

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y8.64%

3Y14.52%

TTM-0.17%

Profit (Net Income) CAGR

10Y-

5Y-56.87%

3Y-78.63%

TTM654.55%

EPS CAGR

10Y-

5Y-56.1%

3Y-77.46%

TTM828.57%

ROCE

10Y Avg38.5%

5Y Avg-4.44%

3Y Avg-9%

Latest7.49%

Peer Comparison

Addiction Treatment

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
INDVIndivior PLC	4.11B	32.89	2192.33	8.69%	14.06%		0.17%

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	968.89M	1.15B	959.92M	785M	647M	791M	901M	1.09B	1.19B
Revenue Growth %	-	0.18%	-0.16%	-0.18%	-0.18%	0.22%	0.14%	0.21%	0.09%
Cost of Goods Sold+	110.81M	122.9M	134.68M	140M	97M	127M	151M	174M	231M
COGS % of Revenue	0.11%	0.11%	0.14%	0.18%	0.15%	0.16%	0.17%	0.16%	0.19%
Gross Profit+	858.08M	1.03B	825.25M	645M	550M	664M	750M	919M	957M
Gross Margin %	0.89%	0.89%	0.86%	0.82%	0.85%	0.84%	0.83%	0.84%	0.81%
Gross Profit Growth %	-	0.19%	-0.2%	-0.22%	-0.15%	0.21%	0.13%	0.23%	0.04%
Operating Expenses+	520.16M	601.89M	508.14M	467M	706M	451M	831M	1.07B	925M
OpEx % of Revenue	0.54%	0.52%	0.53%	0.59%	1.09%	0.57%	0.92%	0.98%	0.78%
Selling, General & Admin	411.18M	508.4M	444.14M	395M	649M	431M	469M	569M	618M
SG&A % of Revenue	0.42%	0.44%	0.46%	0.5%	1%	0.54%	0.52%	0.52%	0.52%
Research & Development	108.98M	93.49M	63.99M	53M	40M	52M	74M	116M	107M
R&D % of Revenue	0.11%	0.08%	0.07%	0.07%	0.06%	0.07%	0.08%	0.11%	0.09%
Other Operating Expenses	0	0	0	19M	17M	-32M	288M	390M	200M
Operating Income+	337.92M	423.32M	317.11M	178M	-156M	213M	-81M	-156M	32M
Operating Margin %	0.35%	0.37%	0.33%	0.23%	-0.24%	0.27%	-0.09%	-0.14%	0.03%
Operating Income Growth %	-	0.25%	-0.25%	-0.44%	-1.88%	2.37%	-1.38%	-0.93%	1.21%
EBITDA+	350.74M	436.97M	332.39M	206M	-130M	235M	-65M	-141M	61M
EBITDA Margin %	0.36%	0.38%	0.35%	0.26%	-0.2%	0.3%	-0.07%	-0.13%	0.05%
EBITDA Growth %	-	0.25%	-0.24%	-0.38%	-1.63%	2.81%	-1.28%	-1.17%	1.43%
D&A (Non-Cash Add-back)	12.82M	13.66M	15.28M	28M	26M	22M	16M	15M	29M
EBIT	136.45M	193M	295.14M	202M	-149M	216M	-62M	-114M	55M
Net Interest Income+	-51M	-42M	-14M	2M	-17M	-22M	-10M	8M	-18M
Interest Income	0	7M	17M	24M	7M	4M	19M	43M	23M
Interest Expense	51M	49M	31M	22M	24M	26M	29M	35M	41M
Other Income/Expense	-51M	-56M	-14M	2M	-17M	-23M	-8M	7M	-18M
Pretax Income+	89.75M	143.91M	265.53M	180M	-173M	190M	-89M	-149M	14M
Pretax Margin %	0.09%	0.13%	0.28%	0.23%	-0.27%	0.24%	-0.1%	-0.14%	0.01%
Income Tax+	57.69M	82.98M	2.87M	46M	-25M	-15M	-44M	-20M	11M
Effective Tax Rate %	0.36%	0.42%	0.99%	0.74%	0.86%	1.08%	0.49%	0.87%	0.14%
Net Income+	32.05M	60.92M	262.67M	134M	-148M	205M	-44M	-129M	2M
Net Margin %	0.03%	0.05%	0.27%	0.17%	-0.23%	0.26%	-0.05%	-0.12%	0%
Net Income Growth %	-	0.9%	3.31%	-0.49%	-2.1%	2.39%	-1.21%	-1.93%	1.02%
Net Income (Continuing)	32.05M	60.92M	262.67M	134M	-148M	205M	-45M	-129M	3M
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	0.22	0.41	1.75	0.92	-1.08	1.31	-0.37	0.01	0.02
EPS Growth %	-	0.86%	3.27%	-0.47%	-2.17%	2.21%	-1.28%	1.04%	0.06%
EPS (Basic)	0.22	0.42	1.81	0.95	-1.08	1.38	-0.37	0.01	0.02
Diluted Shares Outstanding	148.64M	149.7M	150.23M	151.07M	146.57M	154.23M	139.01M	141.8M	133M
Basic Shares Outstanding	143.97M	144.23M	145.43M	146.05M	146.57M	145.66M	139.01M	137.31M	132M
Dividend Payout Ratio	1.97%	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	990M	1.22B	1.33B	1.36B	1.19B	1.44B	1.27B	1.27B	839M
Cash & Short-Term Investments	692M	863M	924M	1.06B	858M	1.1B	897.83M	410M	320M
Cash Only	692M	863M	924M	1.06B	858M	1.1B	778.18M	316M	319M
Short-Term Investments	0	0	0	0	0	0	119.64M	94M	1M
Accounts Receivable	205M	257M	278M	204M	219M	202M	220M	254M	254M
Days Sales Outstanding	77.23	81.7	105.71	94.85	123.55	93.21	89.12	84.82	78.04
Inventory	41M	52M	78M	73M	93M	95M	114.62M	135M	178M
Days Inventory Outstanding	135.05	154.44	211.4	190.32	349.95	273.03	277.05	283.19	281.26
Other Current Assets	40M	38M	49M	0	0	27M	18M	444M	87M
Total Non-Current Assets+	219M	219M	218M	292M	344M	388M	512.76M	499M	481M
Property, Plant & Equipment	27M	54M	57M	107M	103M	95M	85.46M	124M	139M
Fixed Asset Turnover	35.88x	21.26x	16.84x	7.34x	6.28x	8.33x	10.54x	8.81x	8.55x
Goodwill	0	0	0	0	0	0	0	0	2M
Intangible Assets	0	0	0	72M	62M	82M	70M	13M	5M
Long-Term Investments	0	15M	33M	0	0	0	98.53M	41M	26M
Other Non-Current Assets	83M	92M	84M	73M	104M	106M	38.58M	28M	29M
Total Assets+	1.21B	1.44B	1.55B	1.65B	1.53B	1.83B	1.78B	1.76B	1.32B
Asset Turnover	0.80x	0.80x	0.62x	0.48x	0.42x	0.43x	0.51x	0.62x	0.90x
Asset Growth %	-	0.19%	0.07%	0.07%	-0.07%	0.2%	-0.03%	-0.01%	-0.25%
Total Current Liabilities+	1.03B	854M	818M	742M	599M	804M	1.02B	1.29B	939M
Accounts Payable	33M	40M	47M	499M	416M	26M	33M	39M	63M
Days Payables Outstanding	108.7	118.8	127.38	1.3K	1.57K	74.72	79.77	81.81	99.55
Short-Term Debt	101M	5M	4M	9M	12M	3M	3M	12M	18M
Deferred Revenue (Current)	1000K	1000K	1000K	0	0	0	1000K	0	0
Other Current Liabilities	673M	617M	603M	195M	156M	635M	391M	1.16B	802M
Current Ratio	0.96x	1.43x	1.62x	1.83x	1.98x	1.80x	1.24x	0.98x	0.89x
Quick Ratio	0.92x	1.37x	1.53x	1.73x	1.83x	1.68x	1.12x	0.88x	0.70x
Cash Conversion Cycle	103.58	117.34	189.72	-1.02K	-1.09K	291.52	286.41	286.2	259.75
Total Non-Current Liabilities+	474M	793M	663M	701M	850M	825M	702.78M	666M	728M
Long-Term Debt	434M	477M	237M	233M	230M	239M	237M	237M	315M
Capital Lease Obligations	0	0	0	51M	43M	36M	29M	34M	32M
Deferred Tax Liabilities	0	0	0	0	0	0	0	5M	0
Other Non-Current Liabilities	40M	316M	426M	417M	577M	550M	436.78M	390M	381M
Total Liabilities	1.5B	1.65B	1.48B	1.44B	1.45B	1.63B	1.73B	1.96B	1.67B
Total Debt+	535M	482M	241M	293M	285M	286M	277M	283M	375M
Net Debt	-157M	-381M	-683M	-767M	-573M	-816M	-501.18M	-33M	56M
Debt / Equity	-	-	3.65x	1.40x	3.48x	1.41x	5.40x	-	-
Debt / EBITDA	1.53x	1.10x	0.73x	1.42x	-	1.22x	-	-	6.15x
Net Debt / EBITDA	-0.45x	-0.87x	-2.05x	-3.72x	-	-3.47x	-	-	0.92x
Interest Coverage	6.63x	8.64x	10.23x	8.09x	-6.50x	8.19x	-2.79x	-4.46x	0.78x
Total Equity+	-295M	-203M	66M	209M	82M	203M	51.28M	-191M	-348M
Equity Growth %	-	0.31%	1.33%	2.17%	-0.61%	1.48%	-0.75%	-4.72%	-0.82%
Book Value per Share	-1.98	-1.36	0.44	1.38	0.56	1.32	0.37	-1.35	-2.62
Total Shareholders' Equity	-295M	-203M	66M	209M	82M	203M	51.28M	-191M	-348M
Common Stock	72M	72M	73M	73M	73M	70M	68.37M	68M	62M
Retained Earnings	950M	1.03B	1.31B	1.45B	1.31B	1.44B	1.31B	-295M	-454M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	-1.32B	-1.31B	-1.33B	-1.32B	-1.31B	0	-1.34B	-1.35B	-46M
Minority Interest	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	372.72M	309.87M	289.41M	151M	-193M	353M	-4M	-300M	36M
Operating CF Margin %	0.38%	0.27%	0.3%	0.19%	-0.3%	0.45%	-0%	-0.27%	0.03%
Operating CF Growth %	-	-0.17%	-0.07%	-0.48%	-2.28%	2.83%	-1.01%	-74%	1.12%
Net Income	32.05M	60.92M	262.67M	178M	-156M	213M	-44M	-129M	2M
Depreciation & Amortization	12.82M	13.66M	15.28M	28M	26M	22M	16M	15M	29M
Stock-Based Compensation	0	0	0	3M	8M	11M	16M	21M	24M
Deferred Taxes	0	0	0	0	0	0	0	0	6M
Other Non-Cash Items	-65.02M	177.52M	20.06M	21M	-52M	-66M	-110M	87M	16M
Working Capital Changes	309.53M	148.11M	27.7M	-79M	-19M	173M	118M	-294M	-41M
Change in Receivables	-24.73M	-61.97M	-31.52M	79M	15M	-25M	-21M	-33M	-1M
Change in Inventory	3.66M	-6.3M	-29.61M	7M	-16M	-3M	-30M	-15M	-45M
Change in Payables	130.04M	5.25M	55.4M	0	0	0	0	0	0
Cash from Investing+	-32.05M	-45.17M	-3.82M	-2M	-4M	-14M	-222M	-95M	69M
Capital Expenditures	-32.05M	-45.17M	-39.16M	-7M	-4M	-4M	-5M	-8M	-29M
CapEx % of Revenue	0.03%	0.04%	0.04%	0.01%	0.01%	0.01%	0.01%	0.01%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-
Other Investing	0	0	35.34M	5M	0	-10M	1M	-42M	-2M
Cash from Financing+	-134.62M	-88.23M	-226.37M	-13M	-10M	-94M	-101M	-64M	-102M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-
Dividends Paid	-63.19M	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-
Other Financing	12.38M	0	-10.76M	-9M	-7M	-8M	-10M	-22M	-24M
Net Change in Cash	-	-	-	-	-	-	-	-	-
Free Cash Flow+	340.67M	264.7M	250.25M	144M	-197M	319M	-9M	-353M	7M
FCF Margin %	0.35%	0.23%	0.26%	0.18%	-0.3%	0.4%	-0.01%	-0.32%	0.01%
FCF Growth %	-	-0.22%	-0.05%	-0.42%	-2.37%	2.62%	-1.03%	-38.22%	1.02%
FCF per Share	2.29	1.77	1.67	0.95	-1.34	2.07	-0.06	-2.49	0.05
FCF Conversion (FCF/Net Income)	11.63x	5.09x	1.10x	1.13x	1.30x	1.72x	0.09x	2.33x	18.00x
Interest Paid	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	397.98%	97.45%	-101.72%	143.86%	-34.61%	-	-
Gross Margin	88.56%	89.3%	85.97%	82.17%	85.01%	83.94%	83.24%	84.08%	80.56%
Net Margin	3.31%	5.31%	27.36%	17.07%	-22.87%	25.92%	-4.88%	-11.8%	0.17%
Debt / Equity	-	-	3.65x	1.40x	3.48x	1.41x	5.40x	-	-
Interest Coverage	6.63x	8.64x	10.23x	8.09x	-6.50x	8.19x	-2.79x	-4.46x	0.78x
FCF Conversion	11.63x	5.09x	1.10x	1.13x	1.30x	1.72x	0.09x	2.33x	18.00x
Revenue Growth	-	18.5%	-16.39%	-18.22%	-17.58%	22.26%	13.91%	21.31%	8.69%

Revenue by Geography

	2023	2024
UNITED STATES	912M	3M
UNITED STATES Growth	-	-99.67%

Frequently Asked Questions

Growth & Financials

Indivior PLC (INDV) reported $1.18B in revenue for fiscal year 2024. This represents a 22% increase from $968.9M in 2016.

Indivior PLC (INDV) grew revenue by 8.7% over the past year. This is steady growth.

Yes, Indivior PLC (INDV) is profitable, generating $166.0M in net income for fiscal year 2024 (0.2% net margin).

Dividend & Returns

Indivior PLC (INDV) generated $135.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.